Development of a composite scoring algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

被引：0

作者：

Basch, Ethan ^{[1
]}

Becker, Claus ^{[2
]}

Rogak, Lauren J. ^{[3
]}

Schrag, Deborah ^{[4
]}

Reeve, Bryce B. ^{[5
]}

Spears, Patricia ^{[6
]}

Smith, Mary Lou ^{[7
]}

Gounder, Mrinal M. ^{[3
]}

Mahoney, Michelle R. ^{[8
]}

Schwartz, Gary K. ^{[9
]}

Bennett, Antonia V. ^{[10
]}

Mendoza, Tito R. ^{[11
]}

Cleeland, Charles S. ^{[11
]}

Sloan, Jeff A. ^{[8
]}

Abernethy, Amy P. ^{[12
]}

Bruner, Deborah Watkins ^{[13
]}

Schwab, Gisela ^{[14
]}

Atkinson, Thomas M. ^{[3
]}

Thanarajasingam, Gita ^{[15
]}

Bertagnolli, Monica M. ^{[16
]}

Dueck, Amylou C. ^{[17
]}

机构：

[1] Univ N Carolina, Mem Sloan Kettering Canc Ctr, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA

[2] Deciphera Pharmaceut, Waltham, MA USA

[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[4] Harvard Canc Ctr, Dana Farber Partners Canc Care, Boston, MA USA

[5] Duke Univ, Durham, NC USA

[6] Univ N Carolina, Lineberger Comprehens Canc Ctr, Durham, NC USA

[7] Res Advocacy Network, Plano, TX USA

[8] Mayo Clin, Alliance Stat & Data Ctr, Rochester, MN USA

[9] Columbia Univ, New York, NY USA

[10] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA

[11] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[12] US FDA, Silver Spring, MD USA

[13] Emory Univ Hosp, Winship Canc Inst, 1364 Clifton Rd NE, Atlanta, GA 30322 USA

[14] Exelixis Inc, San Francisco, CA USA

[15] Mayo Clin, Div Hematol, Rochester, MN USA

[16] Brigham & Womens Hosp, Alliance Protocol Operat Off, 75 Francis St, Boston, MA 02115 USA

[17] Mayo Clin, Alliance Stat & Data Ctr, Scottsdale, AZ USA

来源：

QUALITY OF LIFE RESEARCH | 2019年 / 28卷

关键词：

D O I：

暂无

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

208.3

引用

页码：S43 / S44

页数：2

共 50 条

[21] Dutch translation and linguistic validation of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE™)
Veldhuijzen, Evalien
Walraven, Iris
Mitchell, Sandra A.
Moore, Elizabeth Yohe
McKown, Shawn M.
Lauritzen, Matthew
Kim, Katherine J.
Belderbos, Jose S. A.
Aaronson, Neil K.
JOURNAL OF PATIENT-REPORTED OUTCOMES, 2020, 4 (01)
[22] Dutch translation and linguistic validation of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Veldhuijzen, Aaltje E.
Belderbos, Jose S. A.
Mitchell, Sandra A.
McKown, Shawn M.
Lauritzen, Matthew
Moore, Elizabeth Yohe
Kim, Katherine J.
Walraven, His
Aaronson, Neil K.
QUALITY OF LIFE RESEARCH, 2018, 27 : S67 - S68
[23] Psychometric validity of the Japanese version of Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Azuma, Kanako
Kawaguchi, Takashi
Miyaji, Tempei
Sano, Motohiko
Kim, Soan
Kawahara, Yosuke
Torii, Ayako
Yamada, Yuri
Hirata, Taiki
Ishibashi, Keiichiro
Okubo, Atsushi
Basch, Ethan
Yamaguchi, Takuhiro
QUALITY OF LIFE RESEARCH, 2017, 26 (01) : 100 - 101
[24] Translation and linguistic validation of the US National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™) in 10 languages
Mitchell, Sandra
Moore, Elizabeth Yohe
McKown, Shawn
Poepsel, Timothy
Lauritzen, Matthew
Campbell, Alicyn
Piault, Elisabeth
Zarzar, Katherine
Kim, Katherine
QUALITY OF LIFE RESEARCH, 2018, 27 : S25 - S25
[25] The Japanese version of the national cancer institute’s patient-reported outcomes version of the common terminology criteria for adverse events (Pro-CTCAE): Psychometric validation and discordance between clinician and patient assessments of adverse events
Kawaguchi T.
Azuma K.
Sano M.
Kim S.
Kawahara Y.
Sano Y.
Shimodaira T.
Ishibashi K.
Miyaji T.
Basch E.
Yamaguchi T.
Journal of Patient-Reported Outcomes, 2 (1)
[26] Dutch translation and linguistic validation of the U.S. National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE™)
Evalien Veldhuijzen
Iris Walraven
Sandra A. Mitchell
Elizabeth Yohe Moore
Shawn M. McKown
Matthew Lauritzen
Katherine J. Kim
José S. A. Belderbos
Neil K. Aaronson
Journal of Patient-Reported Outcomes, 4
[27] Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Chung, Arlene E.
Shoenbill, Kimberly
Mitchell, Sandra A.
Dueck, Amylou C.
Schrag, Deborah
Bruner, Deborah W.
Minasian, Lori M.
St Germain, Diane
O'Mara, Ann M.
Baumgartner, Paul
Rogak, Lauren J.
Abernethy, Amy P.
Griffin, Ashley C.
Basch, Ethan M.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2019, 26 (04) : 276 - 285
[28] Danish translation and linguistic validation of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Baeksted, Christina
Nissen, Aase
Pappot, Helle
Bidstrup, Pernille E.
Mitchell, Sandra A.
Basch, Ethan
Dalton, Susanne O.
Johansen, Christoffer
QUALITY OF LIFE RESEARCH, 2015, 24 : 121 - 122
[29] Psychometric evaluation of the pediatric patient-reported outcomes version of the common terminology criteria for adverse events (Pediatric PRO-CTCAE)
Reeve, Bryce
McFatrich, Molly
Lin, Li
Lucas, Nicole
Castellino, Sharon
Withycombe, Janice
Jacobs, Shana
Mack, Jennifer
Freyer, David
Baker, Justin
Maurer, Scott
Josephs, Isabel
Pinheiro, Laura
Petrany, Mary
Dibridge, Sharon
Sung, Lillian
Hinds, Pamela
QUALITY OF LIFE RESEARCH, 2019, 28 : S20 - S21
[30] METHODS FOR REPORTING THE PATIENT-REPORTED OUTCOMES VERSION OF THE COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS (PRO-CTCAE) DATA IN CANCER CLINICAL TRIALS
Zhou, X.
Eid, D.
Gnanasakthy, A.
VALUE IN HEALTH, 2018, 21 : S226 - S226

← 1 2 3 4 5 →